APA (7th ed.) Citation

Carlisle, J. W., Pentz, R. D., & Ramalingam, S. S. (2025). A Response to the Letter to the Editor: “Equipoise Is No Longer a Major Consideration in the Ethical Evaluation of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC”. Journal of thoracic oncology, 20(4), e53. https://doi.org/10.1016/j.jtho.2025.01.025

Chicago Style (17th ed.) Citation

Carlisle, Jennifer W., Rebecca D. Pentz, and Suresh S. Ramalingam. "A Response to the Letter to the Editor: “Equipoise Is No Longer a Major Consideration in the Ethical Evaluation Of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC”." Journal of Thoracic Oncology 20, no. 4 (2025): e53. https://doi.org/10.1016/j.jtho.2025.01.025.

MLA (9th ed.) Citation

Carlisle, Jennifer W., et al. "A Response to the Letter to the Editor: “Equipoise Is No Longer a Major Consideration in the Ethical Evaluation Of Phase 3 Randomized Controlled Trials Involving Precision Oncology Approaches in NSCLC”." Journal of Thoracic Oncology, vol. 20, no. 4, 2025, p. e53, https://doi.org/10.1016/j.jtho.2025.01.025.